These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
507 related items for PubMed ID: 32710514
1. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis. Karaoglan M, Nacarkahya G. J Diabetes; 2021 Feb; 13(2):154-163. PubMed ID: 32710514 [Abstract] [Full Text] [Related]
2. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes. Ming-Qiang Z, Yang-Li D, Ke H, Wei W, Jun-Fen F, Chao-Chun Z, Guan-Ping D. J Pediatr Endocrinol Metab; 2019 Jul 26; 32(7):759-765. PubMed ID: 31216263 [Abstract] [Full Text] [Related]
3. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young. Thanabalasingham G, Pal A, Selwood MP, Dudley C, Fisher K, Bingley PJ, Ellard S, Farmer AJ, McCarthy MI, Owen KR. Diabetes Care; 2012 Jun 26; 35(6):1206-12. PubMed ID: 22432108 [Abstract] [Full Text] [Related]
6. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed. Stanik J, Dusatkova P, Cinek O, Valentinova L, Huckova M, Skopkova M, Dusatkova L, Stanikova D, Pura M, Klimes I, Lebl J, Gasperikova D, Pruhova S. Diabetologia; 2014 Mar 26; 57(3):480-4. PubMed ID: 24323243 [Abstract] [Full Text] [Related]
9. [Clinical characteristics and genetic analysis of children and adolescents with monogenic diabetes]. Fang J, Zhang P, Feng Y, Ding S, Yan L, Li H. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jul 10; 41(7):783-789. PubMed ID: 38946358 [Abstract] [Full Text] [Related]
13. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations. Ben Khelifa S, Martinez R, Dandana A, Khochtali I, Ferchichi S, Castaño L. Gene; 2018 Apr 20; 651():44-48. PubMed ID: 29408271 [Abstract] [Full Text] [Related]
14. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes. Besser RE, Shepherd MH, McDonald TJ, Shields BM, Knight BA, Ellard S, Hattersley AT. Diabetes Care; 2011 Feb 20; 34(2):286-91. PubMed ID: 21270186 [Abstract] [Full Text] [Related]
15. Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy. Tatsi EB, Kanaka-Gantenbein C, Scorilas A, Chrousos GP, Sertedaki A. Pediatr Diabetes; 2020 Feb 20; 21(1):28-39. PubMed ID: 31604004 [Abstract] [Full Text] [Related]
17. Quality of life assessment in patients with HNF1A-MODY and GCK-MODY. Szopa M, Matejko B, Ucieklak D, Uchman A, Hohendorff J, Mrozińska S, Głodzik W, Zapała B, Płatek T, Solecka I, Sani CM, Małecki MT. Endocrine; 2019 May 20; 64(2):246-253. PubMed ID: 30421137 [Abstract] [Full Text] [Related]
18. Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry. Johansson BB, Irgens HU, Molnes J, Sztromwasser P, Aukrust I, Juliusson PB, Søvik O, Levy S, Skrivarhaug T, Joner G, Molven A, Johansson S, Njølstad PR. Diabetologia; 2017 Apr 20; 60(4):625-635. PubMed ID: 27913849 [Abstract] [Full Text] [Related]
19. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications. Kyithar MP, Bacon S, Pannu KK, Rizvi SR, Colclough K, Ellard S, Byrne MM. Diabetes Metab; 2011 Dec 20; 37(6):512-9. PubMed ID: 21683639 [Abstract] [Full Text] [Related]
20. Maturity onset diabetes of the young: identification and diagnosis. McDonald TJ, Ellard S. Ann Clin Biochem; 2013 Sep 20; 50(Pt 5):403-15. PubMed ID: 23878349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]